Nyxoah SA
NASDAQ:NYXH
Nyxoah SA
NASDAQ:NYXH
Price:
4.38
USD
-6.21%
Market Closed
Market Cap:
$150.6m
Relative Value
The Relative Value of one
NYXH
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 4.38 USD,
Nyxoah SA
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NYXH Relative Value
HIDDEN
Multiples Across Competitors
NYXH Competitors Multiples
Nyxoah SA Competitors
Nyxoah SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| BE |
|
Nyxoah SA
NASDAQ:NYXH
|
162.7m USD | 28.8 | -1.9 | -2.2 | -2.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
195.4B USD | 4.4 | 29.9 | 17 | 23.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
172.4B USD | 17.1 | 60.4 | 45.8 | 56.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
140B USD | 5.6 | 43.1 | 21.9 | 26.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
127.3B USD | 3.7 | 26.7 | 15 | 21.7 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.9B USD | 5.5 | 38.3 | 22.8 | 30.5 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.8B EUR | 2 | 21.6 | 12 | 16.9 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
50.2B USD | 11.7 | 47.3 | 33.8 | 37.3 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
50.5B USD | 2.3 | 30 | 11.4 | 19.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.4B USD | 7.5 | 32.5 | 23 | 25.2 | |
| US |
|
Resmed Inc
NYSE:RMD
|
36.6B USD | 6.8 | 24.6 | 17.4 | 19.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
